Clinical importance of inter-episode symptoms in patients with bipolar affective disorder

Journal of Affective Disorders

Volumn 72, Issue SUPPL., 2002, Pages

  Morriss, Richard ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LITHIUM; LITHIUM CARBONATE; NEUROLEPTIC AGENT; OXCARBAZEPINE;

BEHAVIOR THERAPY; BIPOLAR I DISORDER; BIPOLAR MANIA; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYCLOTHYMIA; DEPRESSION; EMOTION; HUMAN; LIFE EVENT; MANIA; MENTAL INSTABILITY; OBSERVATION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEDATION; SIDE EFFECT; SYMPTOMATOLOGY;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DISEASE PROGRESSION; DRUG RESISTANCE; HUMANS; LITHIUM CARBONATE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036985315     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00340-3     Document Type: Conference Paper

References (67)

1. Ahlfors U.G., Baastrup P.C., Dencker S.J., Elgen K., Lingjaerde O., Pedersen V., Schou M., Aaskoven O. Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatr. Scand. 64:1981;226-237.
2. Ahmed M., Morriss R. Assessment and management of rapid-cycling bipolar affective disorder. Adv. Psychiatric Treat. 3:1997;367-373.
3. Akiskal H.S., Maser J.D., Zeller P., Endicott J., Coryell W., Keller M., Warshaw M., Clayton P., Goodwin F.K. Switching from 'unipolar' to bipolar ll: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatry. 52:1995;114-123.
4. Altman E.S., Rea M.M., Mintz J., Miklowitz D.J., Goldstein M.J., Hwang S. Prodromal symptoms and signs of bipolar relapse: a report based on prospectively collected data. Psychiatric Res. 4:1992;1-18.
5. Bauer M.S., Calabrese J., Dunner D.L., Post R., Whybrow P.C., Gyulai L., Tay L.K., et al. Multisite data reanalysis of the validity of rapid cycling as a modifier for bipolar disorder in DSM-IV. Am. J. Psychiatry. 151:1994;506-515.
6. Bauwens F., Tracy A., Pardoen D., Vander Elst M., Mendlewicz J. Social adjustment of remitted bipolar and unipolar outpatients. A comparison with age-and sex-matched controls. Br. J. Psychiatry. 159:1991;239-244.
7. Benazzi F. Borderline personality disorder and bipolar II disorder in private practice depressed outpatients. Comprehens. Psychiatry. 41:2000;106-110.
8. Bentall, R.P., Kinderman, P., Manson, K., Self-discrepancies in bipolar affective disorder. Cognitive Therapy and Research. in press.
9. Colom F., Vieta E., Martinez-Aran A., Reinares M., Benabarre A., Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J. Clin. Psychiatry. 61:2000;549-555.
10. Coryell W., Endicott J., Maser J.D., Mueller T., Lavori P., Keller M. The likelihood of recurrence in bipolar affective disorder: the importance of episode recency. J. Affect. Disord. 33:1995;201-206.
11. Coryell W., Scheftner W., Keller M., Endicott J., Maser J., Klerman G.L. The enduring psychosocial consequences of mania and depression. Am. J. Psychiatry. 150:1993;720-727.
12. Coryell W., Turvey C., Endicott J., Leon A.C., Mueller T., Solomon D., Keller M. Bipolar I affective disorder: predictors of outcome after 15 years. J. Affect. Disord. 50:1998;109-116.
13. Deltito J., Martin L., Riefkohl J., Austria B., Kissilenko A., Corless C., Morse P. Do patients with borderline personality disorder belong to the bipolar spectrum? J. Affect. Disord. 67:2001;221-228.
14. Dion G.L., Tohen M., Anthony W.A., Waternaux C.S. Symptoms and functioning of patients with bipolar disorder 6 months after hospitalization. Hosp. Commun. Psychiatry. 39:1988;652-657.
15. Donnelly E.F., Murphy D.L. Social desirability and bipolar affective disorder. J. Consult. Clin. Psychol. 41:1973;469.
16. Fava G.A. Measurement of prodromal and subclinical symptoms in mood and anxiety disorders. Fava M., Rosenbaum J.F. Research Designs and Methods in Psychiatry. 1992;223-230 Elsevier, Amsterdam.
17. Fava G.A. Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol. Med. 29:1999;47-61.
18. Fava G.A., Bartolucci G., Rafanelli C., Mangelli L. Cognitive-behavioral management of patients with bipolar disorder who relapsed while on lithium prophylaxis. J. Clin. Psychiatry. 62:2001;556-559.
19. Fava G.A., Grandi S., Zielezny M., Rafanelli C., Canestrari R. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am. J. Psychiatry. 153:1996;945-947.
20. Ferrier I.N., Stanton B.R., Kelly T.P., Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br. J. Psychiatry. 175:1999;246-251.
21. Feske U., Frank E., Mallinger A.G., Houck P.R., Fagiolini A., Shear M.K., Grochocinski V.J., Kupfer D.J. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am. J. Psychiatry. 157:2000;956-962.
22. Gitlin M.J., Swendsen J., Heller T.L., Hammen C. Relapse and impairment in bipolar disorder. Am. J. Psychiatry. 155:1995;646-652.
23. Goldberg J.F., Garno J.L., Leon A.C., Kocsis J.H., Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. J. Clin. Psychiatry. 60:1999;733-740.
24. Goldberg J.F., Harrow M., Grossman L.S. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am. J. Psychiatry. 152:1995;379-384.
25. Goodnick P.J., Fieve R.R., Schlegel A., Kaufman K. Interepisode major and subclinical symptoms in affective disorder. Acta Psych. Scand. 75:1987;597-600.
26. Hammen C., Gitlin M. Stress reactivity in bipolar disorder patients and its relation to prior history of disorder. Am. J. Psychiatry. 154:1997;856-857.
27. Hantouche E.G., Akiskal H.S., Lancrenon S., Allilaire J.F., Sechter D., Azorin J.M., Bourgeois M., Fraud J.P., Chatenet-Duchene L. Systematic clinical methodology for validating bipolar-ll disorder data in mid-stream from a French national multisite study (EPIDEP). J. Affect. Disord. 50:1998;163-173.
28. Henry C., Sorbara F., Lacoste J., Gindre C., Leboyer M. Antidepressant-induced mania in bipolar patients: identification of risk factors. J. Clin. Psychiatry. 62:2001;249-255.
29. Hollander E., Allen A., Lopez R.P., Bienstock C.A., Grossman R., Siever L.J., Merkatz L., Stein D.J. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J. Clin. Psychiatry. 62:2001;199-203. http://www.mdf.org.uk.
30. Jiang H.K. A prospective one-year follow-up study of patients with bipolar disorder. Chung Hua I Hsueh Tsa Chih (Taipei). 62:1999;477-486.
31. Johnson S.L., Roberts J.E. Life events and bipolar disorder: implications from biological theories. Psychol. Bull. 117:1995;434-449.
32. Johnson S.L., Sandrow D., Meyer B., Winters R., Miller I., Solomon D., Keitner G. Increases in manic symptoms after life events involving goal attainment. J. Abnorm. Psychol. 109:2000;721-727.
33. Joyce P.R. Illness behaviour and rehospitalization in bipolar affective disorder. Psychol. Med. 15:1985;521-525.
34. Kay J.H., Altshuler L.L., Ventura J., Mintz J. Prevalence of axis II comorbidity in bipolar patients with and without alcohol use disorders. Ann. Clin. Psychiatry. 11:1999;187-195.
35. Keitner G.L., Solomon D.A., Ryan C.E., Miller I.W., Mallinger A., Kupfer D.J., Frank E. Prodromal and residual symptoms in bipolar I disorder. Compr. Psychiatry. 37:1996;362-367.
36. Keller M.B., Lavori P.W., Kane J.M., Gelenberg A.J., Rosenbaum J.F., Walzer E.A., Baker L.A. Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum levels of lithium. Arch. Gen. Psychiatry. 49:1992;371-376.
37. Kessing L.V. The effect of comorbid alcoholism on recurrence in affective disorder: a case register study. J. Affect. Disord. 53:1999;49-55.
38. Kusznir A., Cooke R.G., Young L.T. The correlates of community functioning in patients with bipolar disorder. J. Affect. Disord. 61:2000;81-85.
39. Lam D., Wong G. Prodromes, coping strategies, insight and social functioning in bipolar affective disorders. Psychol. Med. 27:1997;1091-1100.
40. Lam D.H., Bright J., Jones S., Hayward P., Shuck N., Chisolm D., Sham P. Cognitive therapy for bipolar illness - a pilot study of relapse prevention. Cog. Ther. Res. 24:2000;503-520.
41. Linehan M.M., Armstrong H.E., Suarez A., Allmon D., Heard H.L. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch. Gen. Psychiatry. 48:1991;1060-1064.
42. MacKinnon D.F., Zandi P.P., Cooper J., Potash J.B., Simpson S.G., Gershon E., Nurnberger J., Reich T., DePaulo J.R. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am. J. Psychiatry. 159:2002;30-35.
43. Malkoff-Schwartz S., Frank E., Anderson B.P., Hlastala S.A., Luther J.F., Sherrill J.T., Houck P.R., Kupfer D.J. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol. Med. 30:2000;1005-1016.
44. Malkoff-Schwartz S., Frank E., Anderson B.P., Sherrill J.T., Siegel I., Patterson D., Kupfer D.J. Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation. Arch. Gen. Psychiatry. 55:1998;702-707.
45. Miklowitz D.J., Goldstein M.J., Nuechterlein K.H., Snyder K.S., Mintz J. Family factors and the course of bipolar affective disorder. Arch. Gen. Psychiatry. 45:1988;225-231.
46. Miklowitz D.J., Simonteau T.L., George E.L., Richards J.A., Kalberg A., Sachs-Ericsson N., Suddath R. Family-focused treatment of bipolar disorder; 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biol. Psychiatry. 48:2000;582-592.
47. Molnar G., Fava G.A., Zielezny M., Spinks M.T., Loretan A. Measurement of subclinical changes during lithium prophylaxis. Psychopathology. 20:1987;155-161.
48. Molnar G., Feeney M., Fava G. The duration and symptoms of bipolar prodromes. Am. J. Psychiatry. 145:1988;1575-1578.
49. Muller-Oerlinghausen B. Does effective lithium prophylaxis result in a symptom free-state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization. Compr. Psychiatry. 41:2000;26-31.
50. Paykel E.S., Scott J., Teasdale J., Johnson A.L., Garland A., Moore R., Jenaway A., Cornwall P.L., Hayhurst H., Abbott R., Pope M. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch. Gen. Psychiatry. 56:1999;829-835.
51. Perry A., Tarrier N., Morriss R., McCarthy E., Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. Br. Med. J. 318:1999;149-153.
52. Pini S., Dell'Osso L., Mastrocinque C., Marcacci G., Papasogli A., Vignoli S., Pallanti S., Cassano G. Axis I comorbidity in bipolar disorder with psychotic features. Br. J. Psychiatry. 175:1999;467-471.
53. Pinto O., Akiskal H.S. Lamotrigine as a promising approach to borderline personality: a report of a case series without major mood disorders. J. Affect. Disord. 51:1998;333-343.
54. Post R., Rubinow D.R., Ballinger J.C. Conditioning and sensitisation in the longitudinal course of affective disorder. Br. J. Psychiatry. 149:1986;191-201.
55. Reilly-Harrington N.A., Alloy L.B., Fresco D.M., Whitehouse W.G. Cognitive styles and life events interact to predict bipolar and unipolar symptomatology. J. Abnorm. Psychol. 108:1999;567-578.
56. Rubinztein J.S., Michael A., Paykel E.S., Sahakian B.J. Cognitive impairment in remission in bipolar affective disorder. Psychol. Med. 30:2000;1025-1036.
57. Sachs G.S., Printz D.J., Kahn D.A., Carpenter D., Docherty J.P. The expert consensus guideline series: medication treatment of bipolar disorder. Postgrad. Med. Report. 2000:2000;1-104.
58. Scott J., Garland A., Moorhead S. A pilot study of cognitive therapy in bipolar disorders. Psychol. Med. 31:2001;459-467.
59. Scott J., Stanton B., Garland A., Ferrier I. Cognitive vulnerability in bipolar disorders. Psychol. Med. 30:2000;467-472.
60. Simhandl C., Denk E., Thau K. The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders. J. Affect. Disord. 28:1993;221-231.
61. Smith J., Tarrier N. Prodromal symptoms in manic depressive psychosis. Soc. Psychiatry Psychiatric Epidemiol. 27:1992;245-248.
62. Solomon D.A., Ristow W.R., Keller M.B., Kane J.M., Gelenberg A.J., Rosenbaum J.F., Warshaw M.G. Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am. J. Psychiatry. 153:1996;1301-1307.
63. Sonne S.C., Brady K.T. Substance abuse and bipolar comorbidity. Psychiatric Clin. North Am. 22:1999;609-627.
64. Strawkowski S.M., DelBello M.P. The co-occurrence of bipolar and substance misuse disorders. Clin. Psychol. Rev. 20:2000;191-206.
65. Tondo L., Baldessarini R.J., Hennen J., Minnai G.P., Salis P., Scamonatti L., Masia M., Ghiani C., Mannu P. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J. Clin. Psychiatry. 60:1999;63-69.
66. Weiss R.D., Griffin M.L., Mirin S.M. Drug abuse as self-medication for depression: an empirical study. Am. J. Drug Alcohol Abuse. 18:1992;121-129.
67. Winokur G., Turvey C., Akiskal H., Coryell W., Solomon D., Leon A., Mueller T., Endicott J., Maser J., Keller M. Alcoholism and drug abuse in three groups - bipolar 1, unipolars and their acquaintances. J. Affect. Disord. 50:1998;81-89.